Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 599

Mayo Clinic enters Elysium in $40m round

The health product developer has now raised more than $71m in debt and equity financing in total having received series C funding from backers including Mayo Clinic Ventures.

Dec 31, 2019

Brooks breaks for Syngenta Ventures

Syngenta Ventures has hired Mark Brooks, who worked on the AICPA/CIMA startup accelerator, as it seeks to replenish its team.

Dec 31, 2019

Mastercard rendezvous with RiskRecon in acquisition deal

Cyber risk intelligence provider RiskRecon has agreed to an acquisition by Mastercard after raising $40m in capital from investors including Dell Technologies Capital.

Dec 30, 2019

Rivian revs up with $1.3bn

Returning investors Ford and Amazon contributed to a round that boosted the electric vehicle developer's funding to more than $2.8bn in 2019 alone.

Dec 27, 2019

DraftKings drives itself to public listing

The Fox Sports and Kraft Group-backed fantasy sports contest operator has gone public through a reverse merger, forming a $3.3bn company that will include betting technology producer SBTech.

Dec 27, 2019

SkySpecs checks in $17m

Evergy Ventures, Equinor Energy Ventures and existing investors Statkraft Ventures and UL Ventures chipped in as the wind power maintenance platform developer took its total funding to $29m.

Dec 23, 2019

F5 finds Shape in $1bn acquisition

Alphabet, Hewlett Packard Enterprise, JetBlue and SingTel are exiting the cybersecurity software producer in a $1bn purchase.

Dec 23, 2019

Ripple wraps up $200m series C

SBI returned for a round that increased the valuation of the blockchain-focused money transfer platform to $10bn from a reported $355m three years ago.

Dec 23, 2019

Johnson & Johnson takes Taris in acquisition deal

MIT's Taris, which is developing a drug delivery system for bladder diseases, has been purchased by Johnson & Johnson.

Dec 23, 2019

Johnson & Johnson takes Taris in acquisition deal

Bristol-Myers Squibb has exited Taris, which is developing a drug delivery system for bladder diseases, in a purchase by Johnson & Johnson.

Dec 23, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here